Psychiatry and Behavioral Sciences

Psychiatry Grand Rounds Speaker

  

         Frances R. Levin, M.D.  

  
SPEAKER BIO
 

Frances Rudnick Levin, MD, is the Kennedy-Leavy Professor of Clinical Psychiatry at the College of Physicians and Surgeons of Columbia University.  Director of Clinical and Educational Activities for the Division on Substance Abuse and Columbia University/New York State Psychiatric Institute and Director of the Addiction Psychiatry Fellowship Program at Columbia University/New York Presbyterian Hospital.  Dr. Levin received her medical degree from Cornell University Medical College and completed her residency at the New York Hospital-Payne Whitney Clinic.

She is the principal investigator on several federally funded grants, principal investigator on a T32 NIDA funded Substance Abuse Research Fellowship, and co-principal investigator on several other grants.  She is also a recipient of an independent scientist grant from the National Institute of Drug Abuse.  Her research interests include pharmacologic treatment interventions for cocaine abuse, psychotherapeutic and pharmacologic interventions for marijuana dependence, and treatment approaches for substance abusers with attention-deficit hyperactivity disorder and other psychiatric illnesses.  Dr. Levin has over 100 articles and book chapters to her credit in the area of substance abuse and/or dual diagnosis.  She serves on several advisory panels and is a member of the NIDA – Initial Review Group:  Training and Career Development Subcommittee. 

  
  
  
  
      OBJECTIVES                                                                                                                                                               
         At the completion of this session, the participant should be able to:
       1) Provide reasons for the importance of a developmental and longitudinal history as
    contrasted with a cross-sectional DSM symptom criteria approach when assessing
    the substance patient who may have comorbid ADHD.
2) Identify the barriers to properly diagnosing ADHD in adult substance abusers that lead
    to under and overdiagnosis of ADHD in adult substance abusers.
3) Describe strategies necessary to manage the treatment complications of ADHD in substance
    abusers to implement effective pharmacological and psychosocial treatment.
         
 

« back to February calendar

 
 
 

© 2014  Medical University of South Carolina | Disclaimer